124 related articles for article (PubMed ID: 35856762)
1. Impact of the COVID-19 Pandemic on Characteristics of Cutaneous Tumors Treated by Mohs Micrographic Surgery.
Croley JA; Hoyer P; Wagner RF; Joseph AK
Cutis; 2022 May; 109(5):272-276. PubMed ID: 35856762
[TBL] [Abstract][Full Text] [Related]
2. Impact of the COVID Pandemic on Mohs Micrographic Surgery: A Nationwide Survey.
Seger E; Neill B; Hocker T; Ibrahimi O
J Drugs Dermatol; 2022 May; 21(5):545-547. PubMed ID: 35533028
[TBL] [Abstract][Full Text] [Related]
3. Mohs micrographic surgery for cutaneous malignancies: A focus review of its indications in pediatric age groups.
Le ST; Kamal HY; Khachemoune A
Pediatr Dermatol; 2018 Jul; 35(4):434-440. PubMed ID: 29575263
[TBL] [Abstract][Full Text] [Related]
4. Underutilization of Mohs Micrographic Surgery for Less Common Cutaneous Malignancies in the United States.
Ghareeb ER; Dulmage BO; Vargo JA; Balasubramani GK; Beriwal S
Dermatol Surg; 2016 May; 42(5):653-62. PubMed ID: 27054447
[TBL] [Abstract][Full Text] [Related]
5. Impact of COVID-19 on dermatologic surgery: experience of a Midwestern academic practice.
Hamel R; Pollard B; Council ML
Arch Dermatol Res; 2023 Jan; 315(1):85-87. PubMed ID: 34628518
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of non-melanoma skin cancers of the cutaneous perioral and vermilion lip treated by Mohs micrographic surgery.
Queen D; Knackstedt T; Polacco MA; Collins LK; Lee K; Samie FH
J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):305-311. PubMed ID: 30284728
[TBL] [Abstract][Full Text] [Related]
7. Surgical Outcomes of More Than 1300 Cases of Mohs Micrographic Surgeries from a Private Mohs Clinic in Romania.
Stanciu A; Florica CE; Zota A; Tebeica T; Leventer M; Bobirca F
Chirurgia (Bucur); 2020; 115(1):69-79. PubMed ID: 32155401
[No Abstract] [Full Text] [Related]
8. Consistency in Distribution of Facial Skin Cancers Treated With Mohs Micrographic Surgery.
Horeczko J; Hendi A
J Drugs Dermatol; 2022 May; 21(5):506-509. PubMed ID: 35533023
[TBL] [Abstract][Full Text] [Related]
9. Mohs Micrographic Surgery.
Wong E; Axibal E; Brown M
Facial Plast Surg Clin North Am; 2019 Feb; 27(1):15-34. PubMed ID: 30420068
[TBL] [Abstract][Full Text] [Related]
10. Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center.
Chong T; Tristani-Firouzi P; Bowen GM; Hadley ML; Duffy KL
Dermatol Surg; 2015 Aug; 41(8):889-95. PubMed ID: 26066619
[TBL] [Abstract][Full Text] [Related]
11. Mohs micrographic surgery for male genital tumors: Local recurrence rates and patient-reported outcomes.
Lukowiak TM; Perz AM; Aizman L; Kovell RC; Kovach S; Fischer JP; Krausz A; Giordano C; Higgins HW; Shin TM; Sobanko JF; Etzkorn JR; McMurray S; Chelluri R; Guzzo T; Miller CJ
J Am Acad Dermatol; 2021 Apr; 84(4):1030-1036. PubMed ID: 33279645
[TBL] [Abstract][Full Text] [Related]
12. Solid organ transplant recipients presenting for Mohs micrographic surgery: a retrospective case-control study.
Upjohn E; Bhore R; Taylor RS
Dermatol Surg; 2012 Sep; 38(9):1448-55. PubMed ID: 22587392
[TBL] [Abstract][Full Text] [Related]
13. Correlation Between Demographic and Tumor Characteristics in Non-melanoma Skin Cancers Submitted to Mohs Micrographic Surgery.
Weimann ETS; BrandÃo CM; Terzian LR; Paschoal FM; Filho CDSM; Criado PR
In Vivo; 2020; 34(4):2107-2111. PubMed ID: 32606190
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision.
Nosrati A; Berliner JG; Goel S; McGuire J; Morhenn V; de Souza JR; Yeniay Y; Singh R; Lee K; Nakamura M; Wu RR; Griffin A; Grimes B; Linos E; Chren MM; Grekin R; Wei ML
JAMA Dermatol; 2017 May; 153(5):436-441. PubMed ID: 28241261
[TBL] [Abstract][Full Text] [Related]
15. Mohs micrographic surgery: a treatment method for many non-melanocytic skin cancers.
Dokic Y; Nguyen QL; Orengo I
Dermatol Online J; 2020 Apr; 26(4):. PubMed ID: 32621679
[TBL] [Abstract][Full Text] [Related]
16. Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision.
Xiong DD; Beal BT; Varra V; Rodriguez M; Cundall H; Woody NM; Vidimos AT; Koyfman SA; Knackstedt TJ
J Am Acad Dermatol; 2020 May; 82(5):1195-1204. PubMed ID: 31887322
[TBL] [Abstract][Full Text] [Related]
17. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature.
Snow SN; Gordon EM; Larson PO; Bagheri MM; Bentz ML; Sable DB
Cancer; 2004 Jul; 101(1):28-38. PubMed ID: 15221986
[TBL] [Abstract][Full Text] [Related]
18. Curettage prior to Mohs' micrographic surgery for previously biopsied nonmelanoma skin cancers: what are we curetting? Retrospective, prospective, and comparative study.
Jih MH; Friedman PM; Goldberg LH; Kimyai-Asadi A
Dermatol Surg; 2005 Jan; 31(1):10-5. PubMed ID: 15720088
[TBL] [Abstract][Full Text] [Related]
19. Application of Mohs micrographic surgery appropriate-use criteria to skin cancers at a university health system.
Blechman AB; Patterson JW; Russell MA
J Am Acad Dermatol; 2014 Jul; 71(1):29-35. PubMed ID: 24813300
[TBL] [Abstract][Full Text] [Related]
20. Surgical margins required for basal cell carcinomas treated with Mohs micrographic surgery according to tumor features.
Cerci FB; Kubo EM; Werner B; Tolkachjov SN
J Am Acad Dermatol; 2020 Aug; 83(2):493-500. PubMed ID: 32289390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
